Affiliation:
1. Novosibirsk State Medical University of the Ministry of Health of Russia
Abstract
The article provides a summary of the evaluation of efficacy of folate-containing oral contraceptive (Yaz® plus) containing gestagen with antiandrogenic and antimineralocorticoid effect, which, neutralizes the symptoms of primary dysmenorrhea in addition to preventing unwanted pregnancies, and also has registered indications for the treatment of acne.
Reference24 articles.
1. Monakhov SA. Folate-containing antiandrogen oral contraceptives: dermatological aspects. Ginekologiya, 2016, 18 (4): 54-8.
2. Ledina AV. Drospirenone contraceptive: therapeutic and preventive aspects of use. Ginekologiya, 2015, 1: 25-9.
3. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. J Obstet Gynecol. 2006 Aug;108(2):428-41.
4. Khamoshina MB, Lebedeva MG, Artikova NL, Dobretsova TA, Radzinsky VE, ed. Managing the menstrual cycle: new opportunities. Innovations in contraception: flexible prolonged mode and digital dosing technologies: newsletter. M.: Editorial office of the Journal of Status Praesens, 2016.
5. Mgeryan AN, Prilepskaya VN. Contraception with folates: new facets of the problem. Meditsinsky Sovet, 2018, 7: 28-31.